Baseline characteristics of patients initiating mirabegron or antimuscarinics treatment for overactive bladder: Results from the PERSPECTIVE Registry

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 650
	Open Discussion ePosters 3 Scientific Open Discussion Session 35
	Friday 15th September 2017
	13:35 - 13:40 (ePoster Station 7)
	Exhibition Hall
	Overactive Bladder Prospective Study Quality of Life (QoL) Incontinence Outcomes Research Methods
	1. Medical University of South Carolina, 2. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, University of Colorado, Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, 3. University of Calgary, 4. Quintiles IMS, 5. Astellas Pharma Global Development Inc
Presenter
E Eric Rovner
Abstract PDF ePoster PDF Edit Abstract Abstract Centre